USA – Dyania Health, a NYC-based developer of natural language processing technology to drive clinical and synthetic research, raised $5.3m in seed funding.
The round was led by Innospark Ventures with participation from Outsiders Fund, Wild Basin, Big Pi Ventures, and Tau Ventures, Genesis Ventures and TLife Investments.The company intends to use the funds to accelerate scale of algorithms and engineering, product development, and pharmaceutical client support. Founded in 2019 and led by a seasoned entrepreneurial team, NLP data scientists, physicians, and serial drug inventors who have worked at the US’s top institutions including UCLA, Harvard Medical School, Northwell Health, and Kite Pharma, Dyania Health is building HIPAA compliant technology that takes a prescriptive, rule-based approach, utilizing in-house medical and scientific expertise to drive optimal clinical research, bring drugs to market faster, improve patient outcomes, and save patient lives.19/09/2022
